Lincoln Pharmaceuticals Limited

CMPOne Day(%)Weekly(%)Monthly(%)Quarterly(%)Half Yearly(%)Year(%)YTD(%)52 Weeks High52 Weeks Low
236.15 21.29 21.29 21.29 21.29 21.29 21.29 21.29
* Not adjusted for Corporate Action i.e. Bonus / Split / Dividend
Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
6-Jan-16 Firstcall Ind Net Sales & PAT of the company are expected to grow at a CAGR of .. Buy 287 322 11.92

Upcoming Events and Recent Updates

15-Nov-18
Result - Results  ( updated on Nov 15 2018)
14-Nov-18 Lincoln Pharma added this week in RB Model portfolio by stock_rider
14-Nov-18 Do Read Action Rationale of Lincoln Pharma by stock_rider

236.2
(0.0 %)


Analyst Calls / Meets

No Conference Calls.

Management Interviews

23-Sep-16 Rajni Patel, JM..  
11-Aug-16 Mahendra G. Pat..  
14-Jan-15 Mahendra G. Pat..  
14-Feb-11 Mahendra G. Pat..  

Investor Presentations

22-Aug-18 Investor/Anal...
15-Jun-17 Investor/Anal...
15-Feb-17 Investor/Anal...
11-Aug-16 Investor/Anal...
23-Jun-16 Investor/Anal...

Annual Reports
Source: Reportjunction.com

2017-18  
2016-17  
2015-16  
2014-15  
2013-14  

Research Showcase

06-Jan-16
Firstcall Ind -..
Download

Results

15-Nov-18 Results
31-Jan-18 Results
09-Feb-17 Results
10-Nov-16 Results
11-Feb-16 Results

AGM/EGM/Board Meetings

14-Sep-17 - Quarterly Results
09-Feb-17 - Quarterly Results
10-Nov-16 - Quarterly Results & Ot..
27-Oct-16 - Others
30-Sep-16 - Rs.1.0000 per share(10..

RB Model Portfolio

14-Nov-18 stock_rider bought 10000  Shares RB Model Portfolio
20-Dec-16 Aravind1729 bought 19391  Shares RB Model Portfolio
19-Dec-16 Aravind1729 bought 20609  Shares RB Model Portfolio
16-Dec-16 Aravind1729 bought 56204  Shares RB Model Portfolio
14-Dec-16 Aravind1729 bought 13617  Shares RB Model Portfolio

Press Release

No Press Release.

 

Credit Ratings

16-Jan-17 Long-Term Rating ICRA A- / Stable Reaffirmed
16-Jan-17 Short-Term Rating ICRA A2+ Reaffirmed
11-Mar-16 Short-Term Rating ICRA A2+ Reaffirmed
11-Mar-16 Long-Term Rating ICRA A- Reaffirmed
25-Feb-16 Short-Term Rating CRISIL A3+ Reaffirmed

Archived Documents

No Archieved Transcript.